(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid

(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid Basic information
Product Name:(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid
Synonyms:(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid;5,6-DHET;(8Z,11Z,14Z)-5,6-Dihydroxy-8,11,14-icosatrienoic acid;(±)5(6)-DiHET;GFNYAPAJUNPMGH-QNEBEIHSSA-N;(5(6)-DiHET MaxSpecStandard;5,6-dihydroxyicosa-8,11,14-trienoic acid;8,11,14-Eicosatrienoic acid, 5,6-dihydroxy-, (8Z,11Z,14Z)-
CAS:213382-49-1
MF:C20H34O4
MW:338.48
EINECS:
Product Categories:
Mol File:213382-49-1.mol
(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid Structure
(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid Chemical Properties
Boiling point 515.2±50.0 °C(Predicted)
density 1.025±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: 50 mg/ml; PBS pH 7.2: 1 mg/ml
pka4.68±0.10(Predicted)
Safety Information
MSDS Information
(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid Usage And Synthesis
Uses(±)?-5,?6-?Dihydroxy-?8Z,?11Z,?14Z-?eicosatrienoic Acid ((±)?5,?6-DHET) is associated with abnormal lipoprotein oxylipins and metabolic disorders and may contribute to chronic inflammation.
DefinitionChEBI: A DHET obtained by formal dihydroxylation across the 5,6-double bond of arachidonic acid.
(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid Preparation Products And Raw materials

Email:[email protected] [email protected]
Copyright © 2025 Mywellwork.com All rights reserved.